Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Carboplatin in Basal-like Breast Cancer
NCT00589238Phase 2Terminated
- Sponsor
- National Cancer Centre Singapore
- Start
- Jan 2008
- Primary completion
- Jul 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of carboplatin in basal-like breast cancer (BLBC), sponsored by National Cancer Centre Singapore. Started Jan 2008; status: terminated.
02
Drugs
carboplatin
03
Conditions
basal-like breast cancer (BLBC)
Beyond the preview
Go deeper on NCT00589238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00589238.